SEC Form 4 · accession 0001127602-18-015305
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lourdes Weltzien
Officer — EVP, Life Science
Period of report
Apr 24, 2018
Accepted (ET)
Apr 26, 2018 · 12:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 36,685 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $14.30 | Apr 24, 2018 | A | 10,000 | A | — | Apr 24, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1These options are awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant until fully vested on April 24, 2022.